NCT05337189View on ClinicalTrials.gov

A Multicenter Clinical Trial of Urine DNA Testing for Bladder Cancer in China

RecruitingOBSERVATIONAL
Enrollment

482

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

April 15, 2025

Study Completion Date

April 30, 2025

Conditions
Bladder CancerUrocystitisUrinary Bladder StoneUrothelial Carcinoma
Interventions
DIAGNOSTIC_TEST

Urine DNA methylation analysis

Urine specimen will be collected by the subject for the detection of Human Multigene Methylation Detection Kit (Fluorescent PCR Method)

PROCEDURE

medical imaging and/or cystoscopy and/or pathological examination

Subjects will undergo medical imaging and/or cystoscopy and/or pathological examination

Trial Locations (1)

Unknown

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors
collaborator

Guangzhou Xiangkang Medical Research Co., Ltd.

UNKNOWN

lead

Creative Biosciences (Guangzhou) Co., Ltd.

INDUSTRY